[Combined chemotherapy of advanced soft tissue sarcomas using the platinum derivative cisplatin (platidiam)]. 1985

V A Gorbunova, and N F Orel, and V K Kachalov, and N A Besova, and A V Khlebnov

The results of treatment of 69 cases of advanced soft tissue sarcomas are presented. Patients were given various drug schemes including cisplatin. Overall response in the study group was 30%. Tumor appeared sensitive to the treatment in 49%. A combination of carminomycin, methotrexate, cyclophosphamide and cisplatin proved to be the most effective (39%). The scheme was effective in both untreated patients and those previously treated with adriamycin. Hematologic toxicity registered in 67% cases was the most severe complication involved in the treatment with the above drug regimen.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D006402 Hematologic Diseases Disorders of the blood and blood forming tissues. Blood Diseases,Hematological Diseases,Blood Disease,Disease, Blood,Disease, Hematologic,Disease, Hematological,Diseases, Blood,Diseases, Hematologic,Diseases, Hematological,Hematologic Disease,Hematological Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D012509 Sarcoma A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant. Sarcoma, Epithelioid,Sarcoma, Soft Tissue,Sarcoma, Spindle Cell,Epithelioid Sarcoma,Epithelioid Sarcomas,Sarcomas,Sarcomas, Epithelioid,Sarcomas, Soft Tissue,Sarcomas, Spindle Cell,Soft Tissue Sarcoma,Soft Tissue Sarcomas,Spindle Cell Sarcoma,Spindle Cell Sarcomas
D012983 Soft Tissue Neoplasms Neoplasms of whatever cell type or origin, occurring in the extraskeletal connective tissue framework of the body including the organs of locomotion and their various component structures, such as nerves, blood vessels, lymphatics, etc. Neoplasm, Soft Tissue,Neoplasms, Soft Tissue,Soft Tissue Neoplasm

Related Publications

V A Gorbunova, and N F Orel, and V K Kachalov, and N A Besova, and A V Khlebnov
January 1988, Seminars in surgical oncology,
V A Gorbunova, and N F Orel, and V K Kachalov, and N A Besova, and A V Khlebnov
January 1989, Cancer treatment and research,
V A Gorbunova, and N F Orel, and V K Kachalov, and N A Besova, and A V Khlebnov
May 2010, Cancer chemotherapy and pharmacology,
V A Gorbunova, and N F Orel, and V K Kachalov, and N A Besova, and A V Khlebnov
June 1977, Cancer treatment reviews,
V A Gorbunova, and N F Orel, and V K Kachalov, and N A Besova, and A V Khlebnov
January 1994, Srpski arhiv za celokupno lekarstvo,
V A Gorbunova, and N F Orel, and V K Kachalov, and N A Besova, and A V Khlebnov
December 1992, Seminars in oncology,
V A Gorbunova, and N F Orel, and V K Kachalov, and N A Besova, and A V Khlebnov
January 1989, Voprosy onkologii,
V A Gorbunova, and N F Orel, and V K Kachalov, and N A Besova, and A V Khlebnov
October 1984, American journal of clinical oncology,
V A Gorbunova, and N F Orel, and V K Kachalov, and N A Besova, and A V Khlebnov
January 1981, Langenbecks Archiv fur Chirurgie,
V A Gorbunova, and N F Orel, and V K Kachalov, and N A Besova, and A V Khlebnov
January 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Copied contents to your clipboard!